How is coronavirus affecting our operations? Learn more

biomarkers

A Biomarker for Parkinson’s

The Scotsman newspaper reports today (29 August, 23016) that scientists are a step closer to developing a test for early-stage Parkinson’s. Research has shown that a molecule linked to the condition can be detected in samples of spinal fluid. The molecule in question is a protein called alpha synuclein which forms aggregates known as Lewy…

Print this page

Under the Skin

Science Daily reports that researchers from Beth Israel Deaconess Medical Center (BIDMC) have discovered that an important clue to diagnosing Parkinson’s may lie just beneath the skin. In a study scheduled to appear in the October 29th print issue of the journal Neurology and currently published on-line, the investigators report that elevated levels of a…

Print this page

Comprehensive Parkinson’s Biomarker

Perelman School of Medicine researchers at the University of Pennsylvania report the first biomarker results from the Parkinson’s Progression Markers Initiative (PPMI), showing that a comprehensive test of protein biomarkers in spinal fluid have prognostic and diagnostic value in early stages of Parkinson’s disease. Compared to healthy adults, the study found that people with early…

Print this page

Brain-Imaging Technique Can Help Diagnose Movement Disorders

A new University of Florida study suggests a promising brain-imaging technique has the potential to improve diagnoses for the millions of people with movement disorders such as Parkinson’s disease. Science Daily quotes the principal investigator David Vaillancourt:  “The purpose of this study is to identify markers in the brain that differentiate movement disorders which have…

Print this page